Skip to main content
Clinical Trials/NCT01300806
NCT01300806
Completed
Not Applicable

Impact of a Computer-Assisted SBIRT Program in an HIV Care Setting

University of California, San Francisco0 sites210 target enrollmentJuly 2010
ConditionsSubstance Use

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Substance Use
Sponsor
University of California, San Francisco
Enrollment
210
Primary Endpoint
reduced substance use among HIV-positive people
Status
Completed
Last Updated
12 years ago

Overview

Brief Summary

The goal of this research is to assess the impact of the "screening, brief intervention, and referral to treatment" (SBIRT) intervention strategy for harmful substance use among HIV-positive people.

Detailed Description

The specific aims of the study are: 1. To assess the feasibility of conducting SBIRT using (1) a patient self-administered intervention embedded in a web-based Personal Health Record (PHR) compared to (2) a provider-administered SBIRT intervention guided by the Electronic Medical Record (EMR) during clinic appointments. 2. To examine the acceptability of web-based PHRs to conduct and communicate SBIRT compared to EMR-activated SBIRT conducted by clinic staff, from the perspective of the patient and the provider. 3. To assess the impact of SBIRT on risky drug and alcohol use in an HIV/AIDS population and subsequent effects on sexual risk behaviors and antiretroviral therapy (ART) adherence.

Registry
clinicaltrials.gov
Start Date
July 2010
End Date
May 2013
Last Updated
12 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • 18 years of age
  • confirmed prior HIV+ serostatus
  • ability to provide informed consent to be a participant over a 6 month period
  • English or Spanish speaking

Exclusion Criteria

  • Inability to answer questions with interviewer assistance. Not receiving primary care in clinic.

Outcomes

Primary Outcomes

reduced substance use among HIV-positive people

Time Frame: 6 months

Secondary Outcomes

  • technological innovation to improve the quality of medical care(6 months)

Similar Trials